pd-l1 antibody
![]() PD-L1 Antibody |
|||
49251-100ul | SAB | 100ul | EUR 333 |
![]() PD-L1 Antibody |
|||
49251-50ul | SAB | 50ul | EUR 239 |
![]() PD-L1 Antibody |
|||
4059-002mg | ProSci | 0.02 mg | EUR 171.82 |
Description: PD-L1 plays a critical role in induction and maintenance of immune tolerance to self. As a ligand for the inhibitory receptor PDCD1/CD279, PD-L1 modulates the activation threshold of T-cells and limits T-cell effector response (1). The PDCD1/CD279-mediated inhibitory pathway is exploited by tumors to attenuate anti-tumor immunity and facilitate tumor survival (2,3). Through a yet unknown activating receptor, it may costimulate T-cell subsets that predominantly produce interleukin-10 (IL10) (4). |
![]() PD-L1 Antibody |
|||
4059-01mg | ProSci | 0.1 mg | EUR 436.42 |
Description: PD-L1 plays a critical role in induction and maintenance of immune tolerance to self. As a ligand for the inhibitory receptor PDCD1/CD279, PD-L1 modulates the activation threshold of T-cells and limits T-cell effector response (1). The PDCD1/CD279-mediated inhibitory pathway is exploited by tumors to attenuate anti-tumor immunity and facilitate tumor survival (2,3). Through a yet unknown activating receptor, it may costimulate T-cell subsets that predominantly produce interleukin-10 (IL10) (4). |
![]() Anti-PD-L1 antibody |
|||
STJ130022 | St John's Laboratory | 50 µl | EUR 321 |
Description: Programmed death-ligand 1 (PD-L1) is a 40kDa type 1 transmembrane protein that suppresses immune system. PD-L1 is expressed in hematopoietic and nonhematopoietic cells including T cells and B cells and various types of tumor cells. PD-L1 binds to its receptor Programmed death 1 (PD1). During infection or inflammation, PD1PD-L1 interaction is important for preventing autoimmunity. In tumor microenvironments, PD1-PD-L1 interaction provides an immune escape for tumor cells through cytotoxic T-cell inactivation. Expression of this gene in tumor cells is considered to be prognostic in many types of human cancers. In recent years, PDL1 has become an important biomarker and immunotherapy target for many types of malignancies. |
![]() Anti-PD-L1 antibody |
|||
STJ130023 | St John's Laboratory | 50 µl | EUR 321 |
Description: Programmed death-ligand 1 (PD-L1) is a 40kDa type 1 transmembrane protein that suppresses immune system. PD-L1 is expressed in hematopoietic and nonhematopoietic cells including T cells and B cells and various types of tumor cells. PD-L1 binds to its receptor Programmed death 1 (PD1). During infection or inflammation, PD1PD-L1 interaction is important for preventing autoimmunity. In tumor microenvironments, PD1-PD-L1 interaction provides an immune escape for tumor cells through cytotoxic T-cell inactivation. Expression of this gene in tumor cells is considered to be prognostic in many types of human cancers. In recent years, PDL1 has become an important biomarker and immunotherapy target for many types of malignancies. |
![]() Anti-PD-L1 antibody |
|||
STJ130024 | St John's Laboratory | 50 µl | EUR 321 |
Description: Programmed death-ligand 1 (PD-L1) is a 40kDa type 1 transmembrane protein that suppresses immune system. PD-L1 is expressed in hematopoietic and nonhematopoietic cells including T cells and B cells and various types of tumor cells. PD-L1 binds to its receptor Programmed death 1 (PD1). During infection or inflammation, PD1PD-L1 interaction is important for preventing autoimmunity. In tumor microenvironments, PD1-PD-L1 interaction provides an immune escape for tumor cells through cytotoxic T-cell inactivation. Expression of this gene in tumor cells is considered to be prognostic in many types of human cancers. In recent years, PDL1 has become an important biomarker and immunotherapy target for many types of malignancies. |
![]() Anti-PD-L1 antibody |
|||
STJ180217 | St John's Laboratory | 0.1 ml | EUR 280 |
![]() Anti-PD-L1 antibody |
|||
STJ180383 | St John's Laboratory | 0.1 ml | EUR 246 |
![]() Anti-PD-L1 antibody |
|||
STJ190082 | St John's Laboratory | 200 µl | EUR 197 |
Description: Unconjugated Mouse monoclonal to PD-L1 (AS1A7) |
![]() Mouse PD-L1 Antibody |
|||
32903-05111 | AssayPro | 150 ug | EUR 261 |
![]() PD-L1 Conjugated Antibody |
|||
C49251 | SAB | 100ul | EUR 397 |
![]() Anti-PD-L1 Antibody |
|||
A1454-100 | Biovision | EUR 338 |
![]() Anti-PD-L1 Antibody |
|||
A1454-30T | Biovision | EUR 146 |
![]() PD-L1 Antibody [F6A9] |
|||
SD8639-002mg | ProSci | 0.02 mg | EUR 211.02 |
Description: PD-L1 Antibody: Cell-mediated immune responses are initiated by T lymphocytes that are themselves stimulated by cognate peptides bound to MHC molecules on antigen-presenting cells (APC). T-cell activation is generally self-limited as activated T cells express receptors such as PD-1 (also known as PDCD-1) that mediate inhibitory signals from the APC. PD-1 can bind two different but related ligands, PD-L1 and PD-L2. PD-L1 is a B7-related protein that inhibits cell-mediated immune responses by reducing the secretion of IL-2 and IL-10 from memory T cells. This suggests that PD-L1 may be useful in reducing allogenic CD4+ memory T-cell responses to endothelial cells, thereby reducing the likelihood of host immune responses to allografts. |
![]() PD-L1 Antibody [F6A9] |
|||
SD8639-01mg | ProSci | 0.1 mg | EUR 603.02 |
Description: PD-L1 Antibody: Cell-mediated immune responses are initiated by T lymphocytes that are themselves stimulated by cognate peptides bound to MHC molecules on antigen-presenting cells (APC). T-cell activation is generally self-limited as activated T cells express receptors such as PD-1 (also known as PDCD-1) that mediate inhibitory signals from the APC. PD-1 can bind two different but related ligands, PD-L1 and PD-L2. PD-L1 is a B7-related protein that inhibits cell-mediated immune responses by reducing the secretion of IL-2 and IL-10 from memory T cells. This suggests that PD-L1 may be useful in reducing allogenic CD4+ memory T-cell responses to endothelial cells, thereby reducing the likelihood of host immune responses to allografts. |
![]() PD-L1 Antibody [F2G2] |
|||
SD8641-002mg | ProSci | 0.02 mg | EUR 211.02 |
Description: PD-L1 Antibody: Cell-mediated immune responses are initiated by T lymphocytes that are themselves stimulated by cognate peptides bound to MHC molecules on antigen-presenting cells (APC). T-cell activation is generally self-limited as activated T cells express receptors such as PD-1 (also known as PDCD-1) that mediate inhibitory signals from the APC. PD-1 can bind two different but related ligands, PD-L1 and PD-L2. PD-L1 is a B7-related protein that inhibits cell-mediated immune responses by reducing the secretion of IL-2 and IL-10 from memory T cells. This suggests that PD-L1 may be useful in reducing allogenic CD4+ memory T-cell responses to endothelial cells, thereby reducing the likelihood of host immune responses to allografts. |
![]() PD-L1 Antibody [F2G2] |
|||
SD8641-01mg | ProSci | 0.1 mg | EUR 603.02 |
Description: PD-L1 Antibody: Cell-mediated immune responses are initiated by T lymphocytes that are themselves stimulated by cognate peptides bound to MHC molecules on antigen-presenting cells (APC). T-cell activation is generally self-limited as activated T cells express receptors such as PD-1 (also known as PDCD-1) that mediate inhibitory signals from the APC. PD-1 can bind two different but related ligands, PD-L1 and PD-L2. PD-L1 is a B7-related protein that inhibits cell-mediated immune responses by reducing the secretion of IL-2 and IL-10 from memory T cells. This suggests that PD-L1 may be useful in reducing allogenic CD4+ memory T-cell responses to endothelial cells, thereby reducing the likelihood of host immune responses to allografts. |
![]() PD-L1, CD274 |
|||
E6TA00108 | EnoGene | 0.1mg | EUR 343 |
![]() PD-L1 Protein |
|||
20-abx261703 | Abbexa |
|
|
![]() PD-L1 Protein |
|||
20-abx263458 | Abbexa |
|
|
![]() Anti-PD-L1 |
|||
DB-241-0.1 | DB Biotech | 100 μl | EUR 391 |
Description: rabbit monospecific clonal antibodies for ihc-p application; concentrated |
![]() Anti-PD-L1 |
|||
DB-241-0.2 | DB Biotech | 200 μl | EUR 563 |
Description: rabbit monospecific clonal antibodies for ihc-p application; concentrated |
![]() Anti-PD-L1 |
|||
DB-241-0.5 | DB Biotech | 500 μl | EUR 741 |
Description: rabbit monospecific clonal antibodies for ihc-p application; concentrated |
![]() Anti-PD-L1 |
|||
DB-241-1 | DB Biotech | 1 ml | EUR 1209 |
Description: rabbit monospecific clonal antibodies for ihc-p application; concentrated |
![]() Anti-PD-L1 |
|||
DB-241-RTU-15 | DB Biotech | 15 ml | EUR 678 |
Description: rabbit monospecific clonal antibodies for ihc-p application; prediluted (ready to use) |
![]() Anti-PD-L1 |
|||
DB-241-RTU-7 | DB Biotech | 7 ml | EUR 433 |
Description: rabbit monospecific clonal antibodies for ihc-p application; prediluted (ready to use) |
![]() Anti-PD-L1 |
|||
DB241-RTU-15 | DB Biotech | 15 ml | EUR 678 |
Description: rabbit monospecific clonal antibodies for ihc-p application; prediluted (ready to use) |
![]() Anti-PD-L1 |
|||
DB241-RTU-7 | DB Biotech | 7 ml | EUR 433 |
Description: rabbit monospecific clonal antibodies for ihc-p application; prediluted (ready to use) |
![]() PD-L1 Peptide |
|||
46-156P | ProSci | 0.1 mg | EUR 338 |
Description: CD274 / PD-L1 Peptide |
![]() PD-L1 Peptide |
|||
4059P | ProSci | 0.05 mg | EUR 164.75 |
Description: (IN) PD-L1 peptide |
![]() PD-1/PD-L1 inhibitor 2 |
|||
B6023-25 | ApexBio | 25 mg | EUR 438 |
Description: PD-1/PD-L1 inhibitor 2 is a PD-1/PD-L1 interaction inhibitor. |
![]() PD-1/PD-L1 inhibitor 2 |
|||
B6023-5 | ApexBio | 5 mg | EUR 171 |
Description: PD-1/PD-L1 inhibitor 2 is a PD-1/PD-L1 interaction inhibitor. |
![]() PD-1/PD-L1 inhibitor 1 |
|||
B6172-25 | ApexBio | 25 mg | EUR 453 |
Description: IC50: 0.006-0.10 ?MPD-1/PD-L1 inhibitor 1 is a PD-1/PD-L1 interaction inhibitor.Plenty of studies show that blocking the PD-1/PD-Ll interactions can lead to the restorage and augment of T cell activation in many systems. |
![]() PD-1/PD-L1 inhibitor 1 |
|||
B6172-5 | ApexBio | 5 mg | EUR 168 |
Description: IC50: 0.006-0.10 ?MPD-1/PD-L1 inhibitor 1 is a PD-1/PD-L1 interaction inhibitor.Plenty of studies show that blocking the PD-1/PD-Ll interactions can lead to the restorage and augment of T cell activation in many systems. |
![]() PD-1/PD-L1 Inhibitor 2 |
|||
B1050-25 | Biovision | EUR 566 |
![]() PD-1/PD-L1 Inhibitor 2 |
|||
B1050-5 | Biovision | EUR 202 |
![]() PD-1/PD-L1 Inhibitor 1 |
|||
B1213-25 | Biovision | EUR 566 |
![]() PD-1/PD-L1 Inhibitor 1 |
|||
B1213-5 | Biovision | EUR 185 |
![]() Anti-PD-L1/CD274 Antibody |
|||
PA1851 | BosterBio | 100ug/vial | EUR 294 |
![]() Anti-PD-L1/CD274 Antibody |
|||
PB9154 | BosterBio | 100ug/vial | EUR 294 |
![]() Anti-PD-L1/CD274 Antibody |
|||
PB9994 | BosterBio | 100ug/vial | EUR 294 |
![]() Anti-CD274 / PD-L1 antibody |
|||
STJ70646 | St John's Laboratory | 100 µg | EUR 359 |
![]() anti- PD-L1/CD274 antibody |
|||
FNab06280 | FN Test | 100µg | EUR 505.25 |
Description: Antibody raised against PD-L1/CD274 |
![]() anti- PD-L1/CD274 antibody |
|||
FNab06281 | FN Test | 100µg | EUR 548.75 |
Description: Antibody raised against PD-L1/CD274 |
![]() Anti-PD-L1 Antibody (IHC411) |
|||
A1549-50 | Biovision | EUR 185 |
![]() Anti-PD-L1/CD274 antibody |
|||
PAab06280 | Lifescience Market | 100 ug | EUR 355 |
![]() Ribosome-inactivating protein PD-L1 / PD-L2 Antibody |
|||
20-abx319445 | Abbexa |
|
|
![]() Ribosome-inactivating protein PD-L1/PD-L2 Antibody |
|||
1-CSB-PA306294LA01PJJ | Cusabio |
|
|
Description: A polyclonal antibody against Ribosome-inactivating protein PD-L1/PD-L2. Recognizes Ribosome-inactivating protein PD-L1/PD-L2 from Phytolacca dioica. This antibody is Unconjugated. Tested in the following application: ELISA |
![]() B7-H1/PD-L1 |
|||
E21-315 | EnoGene | 10ug | EUR 343 |
![]() PD-L1 Rabbit pAb |
|||
A11273-100ul | Abclonal | 100 ul | EUR 308 |
![]() PD-L1 Rabbit pAb |
|||
A11273-200ul | Abclonal | 200 ul | EUR 459 |
![]() PD-L1 Rabbit pAb |
|||
A11273-20ul | Abclonal | 20 ul | EUR 183 |
![]() PD-L1 Rabbit pAb |
|||
A11273-50ul | Abclonal | 50 ul | EUR 223 |
![]() PD-L1 Rabbit pAb |
|||
A1645-100ul | Abclonal | 100 ul | EUR 308 |